Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Millennium Earns Velcade Sales Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News

Millennium Earns Velcade Sales Milestone

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Millennium Pharmaceuticals will receive a $40 million payment from J&J subsidiary Ortho Biotech Products, L.P. for achieving a sales milestone in 2007 for Velcade outside the U.S.

The two companies entered into an agreement in June 2003 for the commercialization and continued development of the drug. Under the terms of the agreement, Ortho Biotech and its affiliate, Janssen-Cilag, commercialize Velcade outside of the U.S. and Millennium receives royalties on sales outside of the U.S. Millennium is also eligible to receive payments for achieving clinical, development and regulatory approvals and sales milestones outside of the U.S.

“Velcade is the market leader in the relapsed multiple myeloma setting with a pending approval in the front-line setting,” said Christophe Bianchi, M.D., executive vice president, commercial, Millennium. “This milestone payment represents the continued strong growth of the product worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters